Alpha Teknova (TKNO) Net Equity Issued and Repurchased (2023 - 2024)
Alpha Teknova's (TKNO) quarterly Net Equity Issued and Repurchased came in at $15.1 million in Q3 2024, down 33.93% year-on-year from $22.9 million in Q4 2023, and up 41021.62% on a QoQ basis from -$37000.0 in Q1 2024.
Alpha Teknova (TKNO) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends
Alpha Teknova (TKNO) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $15.1 million in Q3 2024.
- On a quarterly basis, Net Equity Issued and Repurchased fell 33.93% year-over-year to $15.1 million in Q3 2024; TTM through Dec 2025 was $15.1 million, a 0.24% change from a year earlier, with the FY2024 full-year figure at $15.1 million, down 32.88% from the prior year.
- Net Equity Issued and Repurchased for Q3 2024 stood at $15.1 million, up from -$37000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for TKNO reached as high as $22.9 million in Q3 2023 and fell as low as -$412000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 15.14 Mn |
| Sep 30, 2024 | 15.14 Mn |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2023 | -412,000.00 |
| Dec 31, 2023 | -412,000.00 |
| Sep 30, 2023 | 22.92 Mn |
| Sep 30, 2023 | 22.92 Mn |